Biomarin Pharmaceutical reported $5.9B in Assets for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Acadia Pharmaceuticals ACAD:US $ 724.43M 30.74M
Acceleron Pharma XLRN:US $ 836.05M 39.74M
Acorda Therapeutics ACOR:US $ 491.5M 92.55M
Agios Pharmaceuticals AGIO:US $ 1874.6M 613.83M
Alexion Pharmaceuticals ALXN:US $ 18650.2M 547.2M
Alnylam Pharmaceuticals ALNY:US $ 3509.43M 254.16M
Amgen AMGN:US $ 59773M 2766M
Arena Pharmaceuticals ARNA:US $ 1084.66M 99.28M
Bayer BAYN:GR € 114427M 4350M
Biogen BIIB:US $ 24470.4M 615.7M
Biomarin Pharmaceutical BMRN:US $ 5898.5M 93.44M
Bluebird Bio BLUE:US $ 1454.46M 182.82M
Gilead Sciences GILD:US $ 67984M 492M
Gw Pharmaceuticals GWPH:US $ 934.34M 5.17M
Insmed INSM:US $ 1.23B 537.39M
Intercept Pharmaceuticals ICPT:US $ 523.22M 3.11M
IONIS PHARMACEUT IONS:US $ 2497.07M 248.52M
Moderna Inc MRNA:US 16.15B 3.46B
Neurocrine Biosciences NBIX:US $ 1956.4M 110M
Ptc Therapeutics PTCT:US $ 2058.67M 53.27M
Puma Biotechnology PBYI:US $ 260M 1.34M
Regeneron Pharmaceuticals REGN:US $ 21485.9M 3713.7M
Sangamo Biosciences SGMO:US $ 835.36M 41.73M
Sarepta Therapeutics SRPT:US $ 2759.07M 6.16M
Seattle Genetics SGEN:US $ 3952.16M 9.17M
Ultragenyx Pharmaceutical RARE:US $ 1512.44M 85.32M
United Therapeutics UTHR:US $ 4844.9M 203.9M
Vertex Pharmaceuticals VRTX:US $ 12221.69M 106.63M
YTE INCY:US $ 3904.62M 243.19M